In another case, ALK-04, a specific inhibitor of ALKBH5, functioned synchronously to accelerate anti-PD-1 treatment in melanoma, significantly decreasing tumor growth compared to control, by regulating the recruitment of immunosuppressive regulatory T cells and myeloid-derived suppressor cells, and lactate accumulation in the TME (37). This evidence concerns the gene PDCD1 and melanoma.